Searched for
ESOMEPRAZOLE MAGNESIUM
Aurobindo Pharma, Glenmark recall products in USAurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recall...- Glenmark gets USFDA nod to market generic drugGlenmark Pharmaceuticals announced that it has received USFDA approval to market its generic Esomeprazole Magnesium delayed-release capsule...
- Granules India gets USFDA nod for generic drug used for short-term treatment of heartburnGranules India has received approval from the US Food & Drug Administration (USFDA) for its generic Esomeprazole Magnesium delayed-release ...
- Stocks in news: Kotak Mahindra Bank, L&T Finance, HAL, IEX, Blue DartCanada Pension Fund will likely sell partial stake in private lender Kotak Mahindra Bank through block deals today, according to reports.
- Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in USThe drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 4...
- Dr Reddy's recalls 1,752 bottles of heartburn drug in the USThe ongoing Class III recall is on account of "Discolouration" and because the product contains brown pellets, USFDA said. As per the US he...
- Now, antacids must carry ‘kidney injury’ warningNow the anti-acidity pills will carry a side-effect warning of 'acute kidney injury' as a part of their package insert leaflets, following ...
- Glenmark Pharma gets USFDA nod for acid reflux medicationThe approved products is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.
- Aurobindo Pharma gets USFDA nod for heartburn drugAurobindo Pharma said it "has received final approval from the US Food and Drug Administration (USFDA) to manufacture Esomeprazole Magnesiu...
- Aurobindo Pharma gets USFDA nod for gastro reflux drugThe company said the launch of the product is based on the settlement terms/litigation outcome with AstraZeneca.
- Dr Reddy's relaunches generic acid reflux drug in USThe company has "relaunched its Esomeprazole Magnesium delayed-release capsules in the US market. The relaunch is due to a change in the ca...
- Dr Reddy's climbs as drug maker launches Nexium's genericFollowing the development, the DRL stock surged 6.32 per cent to hit a high of Rs 4,222.75. The scrip was nearly 3 per cent away from its 5...
- Dr Reddy's launches Nexium generic in US marketDrug major Dr Reddy's Laboratories (DRL) has launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US mar...
- Dr Reddy's, Endo get FDA approval to launch generic ValcyteThe move comes after Ranbaxy said that FDA had stripped the company of its tentative approval to launch the first copy of the drug.
- Ranbaxy to launch generic Diovan in USRanbaxy’s CEO had said in a conference call that the company is confident that retains the exclusivity opportunities in US and would moneti...
- Ranbaxy may shift key drug filings from Mohali to USConsidering its US facility is already running chock-a-bloc, analysts feel, the company may cherry-pick and transfer its first to file ANDA...
- Ranbaxy to supply raw materials for anti-ulcer drugRanbaxy Laboratories, India's largest company by sales, is expected to start supplying raw materials for anti-ulcer drug esomeprazole magne...
- Ranbaxy strikes deal on Nexium with AstraZenecaRanbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...
- Ranbaxy to sell ulcer drug Nexium in USRanbaxy Pharmaceuticals Inc, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has announced that it has reached an agreement with pha...
- Ranbaxy receives USFDA approval for esomeprazole capsulesRanbaxy Laboratories has received tentative approval from the US Food and Drug Administration for esomeprazole magnesium delayed-release ca...
Load More
